It has been another busy month reporting the latest bariatric and metabolic, and obesity-related disease news. We hope we have brought you the latest and most interesting news as it happened. Here are the Top 10 most read articles on Bariatric News in November 2022.
Remission rates from T2DM were not statistically different after laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) among all patients and among patients with mild, moderate and severe diabetes stratified by the Individualized Metabolic Surgery (IMS) score, according to a study of merged data of two randomized clinical trials - SLEEVEPASS and SM-BOSS.
Complication and death rates were similar for both gastric bypass and sleeve gastrectomy, according to a study by researchers from University of Michigan Health, who compared the two procedures in adolescents covered by Medicaid. The paper, ‘Health Care Use and Adverse Events After Sleeve Gastrectomy and Gastric Bypass Among Adolescents With Severe Obesity Insured by Medicaid’, was published in JAMA.
Bariatric surgery lowered the rates of documented spinal disorders and procedures, as well as reducing the overall rate of healthcare encounters for patients with morbid obesity, according to US researchers. The findings were featured in the paper, ‘Bariatric Surgery Lowers Rates of Spinal Symptoms and Spinal Surgery in a Morbidly Obese Population’, published in Clinical Spine Surgery.
Adults with severe obesity and non-alcoholic fatty liver disease (NAFLD) who underwent bariatric surgery appeared to have a lower cardiovascular disease (CVD) risk than those who received non-surgical care. Reporting their results in the paper, ‘Association of Bariatric Surgery With Cardiovascular Outcomes in Adults With Severe Obesity and Nonalcoholic Fatty Liver Disease‘, published in JAMA Network Open, the Rutgers team, along with collaborators from Ohio State University, reported that patients undergoing bariatric surgery were nearly 50% less likely to develop adverse cardiovascular events such as heart attacks, angina or strokes.
Bariatric and metabolic surgery (BMS) can reduce adverse pregnancy outcomes, according to a study that investigated women’s pregnancy status and outcomes as well as the impact of pregnancy intervals after surgery. The researchers recommended that postoperative patients avoid pregnancy until their weight is stable to reduce the risk of adverse pregnancy outcomes. The findings were featured in the paper, ‘A Retrospective Evaluation of Pregnancy Outcomes Following Bariatric Surgery: A Single-Center Experience’, by researchers from The First Affiliated Hospital of Jinan University, Guangzhou, People’s Republic of China.
Semaglutide is effective in helping adolescents lose weight and improves cardiac health, according to a study, ‘Once-Weekly Semaglutide in Adolescents with Obesity’, published in the New England Journal of Medicine and presented at Obesity Week 2022. In an international phase 3a clinical trial, adolescents with obesity who received once-weekly semaglutide compared to placebo had a 16.1% decrease in their body mass index (BMI) while the BMI of those who took placebo rose by 0.6%.
Millions of Black and Hispanic adults who are living with overweight or obesity are unable to afford the latest treatment in obesity medicine, according to a study by the Yale School of Medicine researchers. The study authors estimated the overall percentage of US adults who were eligible for semaglutide, a recently approved anti-obesity medication, and examined the prevalence of racial and ethnic disparities. They found that a larger proportion of Blacks and Hispanics who would benefit from the medication had substantial financial barriers that would likely block access compared with other groups.
The time from bariatric surgery-to-birth had no relevant impact on the assessed health outcomes of the children, according to researchers from the Medical University of Vienna, Vienna, Austria. They found that there were no differences noted in frequency of hospitalisation and diagnoses leading to hospitalisation in the first year of life, regardless of the surgery-to-delivery interval. The findings were featured in the paper, ‘The Timing of Pregnancies After Bariatric Surgery has No Impact on Children’s Health—a Nationwide Population-based Registry Analysis’, published in Obesity Surgery.
Boston Scientific has entered into a definitive agreement to acquire Apollo Endosurgery, for a cash price of $10 per share, reflecting an enterprise value of approximately US$615 million. Apollo Endosurgery is expected to generate net sales of approximately US$76 million in 2022, as a result of the expected growth in its endoscopic suturing system franchise, including its OverStitch Endoscopic Suturing System, OverStitch Sx Endoscopic Suturing System and X-Tack Endoscopic HeliX Tacking System.
The annual number of paediatric metabolic and bariatric surgery (MBS) procedures in the US more than doubled between 2010 and 2017, but Black And Hispanic teens accounted for a disproportionately low percentage of the procedures despite them having a higher prevalence of obesity than their white counterparts. The findings, 'National Trends in Pediatric Metabolic and Bariatric Surgery: 2010–2017', were published in the journal Pediatrics.
Thank you for visiting Bariatric News.